Effect of aspirin combined with perindopril on prostacyclin, thromboxone A2, and norepinephrine in the blood of arteriosclerosis rabbit models and the cardiac function

Bulletin of Hunan Medical University

Volumn 28, Issue 1, 2003, Pages 37-40

  Zhuang, Han ping ^a   Li, Jing ^a   Liu, Li hua ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Arteriosclerosis; Aspirin; Cardiac function; Laboratory animals; Perindopril; Rabbit

Indexed keywords

ACETYLSALICYLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NORADRENALIN; PERINDOPRIL; PROSTACYCLIN; THROMBOXANE A2; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOSCLEROSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; HEART FUNCTION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RATE; LOW DRUG DOSE; NONHUMAN; RABBIT;

ANIMALS; ARTERIOSCLEROSIS; ASPIRIN; DRUG SYNERGISM; EPOPROSTENOL; FEMALE; HEART FUNCTION TESTS; HEART RATE; MALE; NOREPINEPHRINE; PERINDOPRIL; RABBITS; RANDOM ALLOCATION; THROMBOXANE A2; THROMBOXANE B2;

EID: 0038204662     PISSN: 10005625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Fonarow GC, Gawlinski A, Moughrabi S, et al. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)[J]. Am J Cardiol, 2001, 87: 819-822.
2. Seydi N, Maruyzma R, Levi R, et al. Bradykinin activates a cross-signaling pathway between sensory and adrenergic nerve endings in the heart: a novel mechanism of ischemic norephinephrine release [J]? J Pharmacol Exp Ther, 1999, 290: 656-663.
3. Takkouche B, Etminan M, Caamano F, et al. Interaction between aspirin and ACE Inhibitors: resolving discrepancies using a meta-analysis[J]. Drug Saf, 2002, 25: 373-378.
4. Wojakowski W, Gminski J, Siemianowicz K, et al. The influence of angiotensin converting enzyme inhibitors on lipid peroxidation in sera and aorta of rabbits in diet-induced hypercholesterolemia[J]. Int J Mol Med, 2000, 6: 591-594.
5. Davie AP, McMurray JJ. Effect of aspirin on vasodilation to bradykinin and substance P in patients with heart failure treated with ACE inhibitor[J]. Br J Clin Pharmacol, 2002, 53: 37-42.
6. Hatta E, Maruyama R, Marshall SJ, et al. Bradykinin promotes ischemic norepinephrine release in guinea pig and human hearts[J]. J Pharmacol Exp Ther, 1999, 288: 919-927.
7. Hatta E, Yasuda K, Levi R. Activation of histamine H3-receptors inhibits carrier-mediated norepinephrine release in a human model of protracted myocardial ischemia [J]. J Pharmacol Exp Ther, 1997, 283: 494-500.
8. Lapointe N, Blais C Jr, Adam A, et al. Comparison of the effects of an angiotensin-converting enzyme inhibitor and a vasopeptidase inhibitor after myocardial infarction in the rat [J]. J Am Coll Cardiol, 2002, 39: 1692-1698.
9. Fukuzawa S, Ozawa S, Inagaki M, et al. Angiotensin-converting enzyme inhibitor therapy affects myocardial fatty acid metabolism after acute myocardial infarction [J]. J Nucl Cardiol, 2000, 7: 23-28.